RBC Capital Maintains Outperform on Privia Health Gr, Raises Price Target to $32
RBC Capital analyst Ryan Halsted maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and raises the price target from $31 to $32.
Follow the latest Privia Health Group, Inc. (PRVA) news and market headlines alongside the live PRVA price. Stay informed on what's moving PRVA.
RBC Capital analyst Ryan Halsted maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and raises the price target from $31 to $32.
Privia Health Gr (NASDAQ:PRVA) raises FY2026 sales outlook from $2.500 billion-$2.550 billion to $2.550 billion-$2.600 billion vs $2.457 billion estimate.
News and data on this page is provided by our partnered third-party news and market data provider, with the original publisher credited on each article. All third-party content reflects the views of the original publisher and does not represent the views of MEXC. Price and market data shown on this page are provided by third-party data providers and may be delayed. MEXC offers trading products related to PRVA, including RealStocks and Stock Futures.
The content on this page is provided for informational purposes only and does not constitute investment, financial, or trading advice. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of any news or market data shown. Trading U.S. stocks and related products involves significant risk, and prices can move sharply in a short period. Past performance does not guarantee future results. Please conduct your own research and assess your financial situation and risk tolerance before making any investment decisions. MEXC is not liable for any losses arising from the use of this information.